Inventor
Anzhelika Kabro
Inventor
Montreal, CA
Overview
Patents· 9 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Pprimary
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations35%
C07DHeterocyclic compounds31%
A61KPreparations for medical, dental or toiletry purposes19%
C07FAcyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium12%
C07BGeneral methods of organic chemistry4%
PatentTitleYear
11,040,957Heteroaromatic compounds useful for the treatment of proliferative diseases202110,906,889Polycyclic inhibitors of cyclin-dependent kinase 7 (CDK7)202110,865,206Inhibitors of cyclin-dependent kinase 7 (CDK7)202010,738,067Inhibitors of cyclin-dependent kinase 7 (CDK7)202010,519,135Inhibitors of cyclin-dependent kinase 7 (CDK7)201910,308,648Inhibitors of cyclin-dependent kinase 7 (CDK7)201910,106,526Inhibitors of cyclin-dependent kinase 7 (CDK7)201810,059,690Inhibitors of cyclin-dependent kinase 7 (CDK7)201810,047,070Polycyclic inhibitors of cyclin-dependent kinase 7 (CDK7)2018Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2018–2021Patents assigned to SYROS PHARMACEUTICALS INC (7)· patent assignee history
2018–2021Patents assigned to DANA FARBER CANCER INST INC (3)· patent assignee history
2018–2021Based in Montreal, CA· patent location history
2019Based in Lachine, CA· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| SYROS PHARMACEUTICALS INC | 7 | 2018–2021 |
| DANA FARBER CANCER INST INC | 3 | 2018–2021 |
Locations
| Location | Patents | Span |
|---|---|---|
| Montreal, CA | 8 | 2018–2021 |
| Lachine, CA | 1 | 2019 |